Everest Medicines Ties With Tencent to Scale Last Mile to Patient Care
Back-to-back deals with Tencent and Medbanks Health seek to build new distributing partnerships ahead of expected first drug approvals Key points: Everest Medicines could gain valuable distribution channels through its…
RELATED ARTICLES
-
Everest Medicines eyes mRNA tumor vaccines as drug valuations rebound
1952.HK -
Everest Medicines drives growth with AI-powered mRNA pipeline
1952.HK
-
Everest gets boost from core product Nefecon’s inclusion in China’s national health plan
1952.HK
-
Earnings blow for CSPC Pharma as the state drives a hard bargain
1093.HK
-
BRIEF: Everest unveils positive results for kidney drug EVER001 in Phase 1b/2a trial
1952.HK
-
Xuanzhu Biopharm set for spin-off in Hong Kong IPO
0460.HK
- TCMTech fuses old with the new by mixing AI and Chinese medicine
